Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)

Current Medical Research and Opinion
David PariserLaurent Eckert

Abstract

Objectives: The Atopic Dermatitis Control Tool (ADCT) was designed to evaluate patient-perceived AD control and facilitate patient-physician discussion on long-term disease control.Methods: The study was performed in adult patients with AD. Development of the ADCT followed US Food and Drug Administration (FDA) guidelines on patient-reported outcome measures (PROMs). Qualitative research, including targeted literature review, interviews with clinical experts, and combined concept elicitation/cognitive debriefing with patients with AD, was conducted to provide a list of comprehensive concepts capturing AD control per physician and patient perspectives. Quantitative methods assessed psychometric properties of the instrument and defined the threshold for AD control.Results: The resulting pilot six-item ADCT, reflecting key concepts related to AD control, had 7-day recall and assessed symptoms and impacts on patients' everyday lives by severity and/or frequency. The ADCT showed good content validity (well understood by adult patients with AD), and quick completion time (<2 min). Psychometric analysis indicated no floor/ceiling effects for response distributions, particularly strong (r ≥ 0.80) inter-item correlations for the six ADCT...Continue Reading

References

May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology
Aug 26, 1998·The American Journal of Cardiology·W R Daley
Jul 10, 2001·Journal of Cutaneous Medicine and Surgery·M M ChrenL P Sands
Dec 13, 2006·Journal of Clinical Epidemiology·Caroline B TerweeHenrica C W de Vet
Oct 4, 2007·The Journal of Allergy and Clinical Immunology·Jochen SchmittUNKNOWN European Dermato-Epidemiology Network
Nov 13, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marlene H FrostUNKNOWN Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group;
Jun 16, 2010·Annals of Dermatology·Thomas Bieber
Mar 11, 2011·The Journal of Allergy and Clinical Immunology·Emma Guttman-YasskyJames G Krueger
Jun 21, 2011·Immunological Reviews·Mark Boguniewicz, Donald Y M Leung
Nov 26, 2013·The British Journal of Dermatology·S M LanganK S Thomas
Dec 3, 2013·Journal of the American Academy of Dermatology·Lawrence F EichenfieldRobert Sidbury
Oct 25, 2016·The Journal of Investigative Dermatology·Patrick M BrunnerUNKNOWN Councilors of the International Eczema Council
Mar 23, 2017·JAMA : the Journal of the American Medical Association·Freddie C Hamdy, Jenny L Donovan
Apr 10, 2017·The Journal of Allergy and Clinical Immunology·Donald Y M Leung, Emma Guttman-Yassky
Apr 23, 2017·The British Journal of Dermatology·M J RiddA L Huntley
May 1, 2017·The Journal of Allergy and Clinical Immunology·Sinéad M LanganKim S Thomas
Jun 18, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Cheryl D Coon, Karon F Cook
Feb 8, 2018·The Journal of Allergy and Clinical Immunology·Judith L ThijsDirkJan Hijnen
Aug 22, 2018·International Journal of Integrated Care·Marcel G M Olde RikkertGert P Westert
Jan 27, 2019·BMJ : British Medical Journal·Melanie CalvertNiels Henrik Hjollund

❮ Previous
Next ❯

Citations

Sep 24, 2020·The Journal of Dermatological Treatment·P H LamT F Leung
Apr 12, 2021·The Journal of Allergy and Clinical Immunology. in Practice·Laura MaintzCarolyn Jack
May 13, 2021·Journal of the European Academy of Dermatology and Venereology : JEADV·B L StuartK S Thomas
Aug 28, 2021·Dermatology and Therapy·Jorge SanchezBenjamin Hidalgo
Nov 30, 2021·Acta Dermato-venereologica·Delphine Staumont-SalléJason Shourick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.